Novel, non-invasive imaging approach to identify patients with advanced non-small cell lung cancer at risk of hyperprogressive disease with immune checkpoint blockade

PURPOSE: Hyperprogression is an atypical response pattern to immune checkpoint inhibition that has been described within non-small cell lung cancer (NSCLC). The paradoxical acceleration of tumor growth after immunotherapy has been associated with significantly shortened survival, and currently, ther...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Vaidya, Pranjal, Bera, Kaustav, Patil, Pradnya D, Gupta, Amit, Jain, Prantesh, Alilou, Mehdi, Khorrami, Mohammadhadi, Velcheti, Vamsidhar, Madabhushi, Anant
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Immunotherapy Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7555103/
https://ncbi.nlm.nih.gov/pubmed/33051342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001343
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars